TickerFactsScreenerDevelopers

Actinium Pharmaceuticals, Inc. (ATNM) — Operating Income

Annual figures by fiscal year, from SEC filings.

2010: -$26.1K2011: -$3.28M2012: -$7.95M2013: -$6.59M2014: -$22.48M2015: -$24.83M2016: -$26.85M2017: -$26.91M2018: -$23.83M2019: -$22.07M2020: -$22.39M2021: -$24.96M2022: -$34.10M2023: -$51.92M2024: -$42.12M2025: -$36.25M-$36.25M
2010Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$36.25M+13.9%
2024-$42.12M+18.9%
2023-$51.92M-52.2%
2022-$34.10M-36.6%
2021-$24.96M-11.5%
2020-$22.39M-1.5%
2019-$22.07M+7.4%
2018-$23.83M+11.5%
2017-$26.91M-0.2%
2016-$26.85M-8.1%
2015-$24.83M-10.5%
2014-$22.48M-241.0%
2013-$6.59M+17.1%
2012-$7.95M-142.0%
2011-$3.28M-12503.8%
2010-$26.1K—